Cargando…
The natural alkaloid Jerantinine B has activity in acute myeloid leukemia cells through a mechanism involving c-Jun
BACKGROUND: Acute myeloid leukemia (AML) is a heterogenous hematological malignancy with poor long-term survival. New drugs which improve the outcome of AML patients are urgently required. In this work, the activity and mechanism of action of the cytotoxic indole alkaloid Jerantinine B (JB), was exa...
Autores principales: | Alhuthali, Hayaa Moeed, Bradshaw, Tracey D., Lim, Kuan-Hon, Kam, Toh-Seok, Seedhouse, Claire H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7341637/ https://www.ncbi.nlm.nih.gov/pubmed/32635894 http://dx.doi.org/10.1186/s12885-020-07119-2 |
Ejemplares similares
-
Sustainable Syntheses of (−)-Jerantinines A & E and Structural Characterisation of the Jerantinine-Tubulin Complex at the Colchicine Binding Site
por: Smedley, Christopher J., et al.
Publicado: (2018) -
Apoferritin-Encapsulated Jerantinine A for Transferrin
Receptor Targeting and Enhanced Selectivity in Breast Cancer Therapy
por: Abuzaid, Haneen, et al.
Publicado: (2022) -
Jerantinine A induces tumor-specific cell death through modulation of splicing factor 3b subunit 1 (SF3B1)
por: Chung, Felicia Fei-Lei, et al.
Publicado: (2017) -
Increased FLYWCH1 Expression is Negatively Correlated with Wnt/β-catenin Target Gene Expression in Acute Myeloid Leukemia Cells
por: Almars, Amany, et al.
Publicado: (2019) -
Sequential Treatment with Cytarabine and Decitabine Has an Increased Anti-Leukemia Effect Compared to Cytarabine Alone in Xenograft Models of Childhood Acute Myeloid Leukemia
por: Leonard, Sarah M., et al.
Publicado: (2014)